Literature DB >> 12038919

Quality of systematic reviews of economic evaluations in health care.

Tom Jefferson1, Vittorio Demicheli, Luke Vale.   

Abstract

CONTEXT: Reviews performed almost a decade ago showed considerable gaps in the quality of reporting and methods applied to economic evaluations of health care interventions. Measures taken by the research community to address the issue included the promulgation of guidelines and the publicizing of good practice in economic evaluation.
METHODS: To assess the quality of methods of systematic reviews, economic evaluations in health care, and reporting methods, we conducted full-text searches of private and public databases for the period 1990 through March 2001 and corresponded with researchers active in the field. A total of 102 reports were identified, but only 39 were included. Quality of systematic reviews was assessed by a 6-item checklist.
RESULTS: Quality of review methods was reasonable, but more attention needs to be paid to search methods and standardization of evaluation instruments. The reviews found consistent evidence of serious methodological flaws in a significant number of economic evaluations. Lack of clear descriptions of methods, lack of explanation and justification for the framework and approach used, and low-quality estimates of effectiveness for the interventions evaluated were the most frequent flaws. Modest improvements in quality of conducting and reporting economic evaluations appear to have taken place in the last decade.
CONCLUSIONS: Proper allocation of resources on the basis of economic evaluations remains uncertain. Editorial teams and regulatory bodies should perform quality assurance based on a single widely accepted and validated standard instrument.

Mesh:

Year:  2002        PMID: 12038919     DOI: 10.1001/jama.287.21.2809

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

1.  A role for two-stage pharmacoeconomic appraisal? Is there a role for interim approval of a drug for reimbursement based on modelling studies with subsequent full approval using phase III data?

Authors:  Suzanne Hill; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops.

Authors:  Guillaume Desjeux; Laurent Galoisy-Guibal; Cyrille Colin
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.

Authors:  Kun-Sei Lee; Werner B F Brouwer; Sang-Il Lee; Hye-Won Koo
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Methodologic quality of cost-effectiveness analyses of surgical procedures.

Authors:  Laura Kruper; Jibby E Kurichi; Seema S Sonnad
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

5.  Author's response to influenza vaccination: policy v evidence.

Authors:  Tom Jefferson
Journal:  BMJ       Date:  2006-12-02

Review 6.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 7.  Systematic review of economic evaluations and cost analyses of guideline implementation strategies.

Authors:  Luke Vale; Ruth Thomas; Graeme MacLennan; Jeremy Grimshaw
Journal:  Eur J Health Econ       Date:  2007-03-09

8.  Methodological reviews of economic evaluations in health care: what do they target?

Authors:  Maria-Florencia Hutter; Roberto Rodríguez-Ibeas; Fernando Antonanzas
Journal:  Eur J Health Econ       Date:  2013-08-24

Review 9.  Bufale Spotting, part 9: assessing an economic evaluation.

Authors:  Tom Jefferson; Lucia Zarra
Journal:  J R Soc Med       Date:  2008-04       Impact factor: 5.344

Review 10.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.